MYGN

#2997
Myriad Genetics Inc
4.9100 USD
+6.97%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.9100
4.9100
Intervallo Annuale
4.1050
8.5000
Variazione giornaliera
+6.97%
Variazione Mensile
+5.36%
Variazione di 6 mesi
-40.63%
Variazione Annuale
-40.63%
Chiusura Precedente
4.5900
Apertura
4.9100
Bid
Ask
Minimo
4.9100
High
4.9100
Volume
129
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 459.1251 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.56
Rapporto prezzo/fatturato
0.69

Myriad Genetics Inc

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

Notizie